HEAD-DROP: A FREQUENT FEATURE OF LATE-ONSET MYASTHENIA GRAVIS

被引:17
|
作者
Sih, Marvin [1 ]
Soliven, Betty [1 ]
Mathenia, Nicholas [1 ]
Jacobsen, John [1 ]
Rezania, Kourosh [1 ]
机构
[1] Univ Chicago, Med Ctr, Dept Neurol, 5841 S Maryland Ave,MC 2030, Chicago, IL 60637 USA
关键词
acetylcholine receptor antibody; dropped head; head-drop; late-onset; MuSK; myasthenia gravis; respiratory weakness; PROTEIN; 4; AUTOANTIBODIES; MUSK; SIGN; MYOPATHY; DISEASE;
D O I
10.1002/mus.25526
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Head-drop is often encountered in myasthenia gravis (MG) patients, but its frequency and clinical course have not been studied systematically. Methods: In a retrospective study of a cohort of MG patients seen over a period of 11 years in a tertiary medical center, we assessed the clinical characteristics of patients who had head-drop. Results: Of 146 generalized MG patients, 15 had head-drop during the course of their disease. Head-drop patients had older age of onset than those who did not have head-drop (mean age of onset 59.1 vs. 42.3 years) and were predominantly men. Head-drop was present in 23% of patients > 60 versus 6% of those < 60 years, and it improved in 9 of 11 patients with treatment directed to generalized MG. Conclusions: Head-drop is a common, treatment-responsive manifestation of late-onset MG.
引用
收藏
页码:441 / 444
页数:4
相关论文
共 50 条
  • [1] Late-onset non-thymomatous myasthenia gravis: Comparison with early-onset and very late-onset myasthenia gravis
    Cho, Eun Bin
    Min, Ju-Hong
    Lee, Sujin
    Yoon, Cindy W.
    Seok, Jin Myoung
    Cho, Hye-Jin
    Lee, Hye Lim
    Kim, Byoung Joon
    NEUROLOGY ASIA, 2017, 22 (02) : 123 - 131
  • [2] Characteristics of late-onset myasthenia gravis
    Saša A. Živković
    Paula R. Clemens
    David Lacomis
    Journal of Neurology, 2012, 259 : 2167 - 2171
  • [3] Characteristics of late-onset myasthenia gravis
    Zivkovic, Sasa A.
    Clemens, Paula R.
    Lacomis, David
    JOURNAL OF NEUROLOGY, 2012, 259 (10) : 2167 - 2171
  • [4] Rituximab in late-onset myasthenia gravis is safe and effective
    Sahai, Supreet K.
    Maghzi, A. Hadi
    Lewis, Richard A.
    MUSCLE & NERVE, 2020, 62 (03) : 377 - 380
  • [5] Clinical characteristics of late-onset myasthenia gravis
    Sun, Chenjing
    Ren, Zhuangzhuang
    Miao, Xiuling
    Zheng, Yanxu
    Zhang, Jun
    Qi, Xiaokun
    Liu, Jianguo
    Qiu, Feng
    HELIYON, 2024, 10 (07)
  • [6] Effects of thymectomy on late-onset myasthenia gravis without thymoma
    Kawaguchi, Naoki
    Kuwabara, Satoshi
    Nemoto, Yuko
    Fukutake, Toshio
    Arimura, Kimiyoshi
    Sarne, Mitsuhiro
    Hattori, Takamichi
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2007, 109 (10) : 858 - 861
  • [7] Antititin antibody in early- and late-onset myasthenia gravis
    Szczudlik, P.
    Szyluk, B.
    Lipowska, M.
    Ryniewicz, B.
    Kubiszewska, J.
    Dutkiewicz, M.
    Gilhus, N. E.
    Kostera-Pruszczyk, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (04): : 229 - 233
  • [8] Dysphonia as First Symptom of Late-Onset Myasthenia Gravis
    Montero-Odasso, Manuel
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (06) : C4 - C6
  • [9] Dysphonia as first symptom of late-onset myasthenia gravis
    Manuel Montero-Odasso
    Journal of General Internal Medicine, 2006, 21 : C4 - C6
  • [10] Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome
    Senay Yildiz Celik
    Hacer Durmus
    Vuslat Yilmaz
    Guher Saruhan Direskeneli
    Yesim Gulsen Parman
    Piraye Serdaroglu Oflazer
    Feza Deymeer
    Acta Neurologica Belgica, 2020, 120 : 133 - 140